andreitkatchenko@protonmail.com
1992 . Ph.D. in Molecular Biology. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
1988. M.D. General Medicine/Biochemistry. Faculty of Medical Biology, Russian National Research Medical University, Moscow, Russia
1988． Master of Science in Molecular Biology, Faculty of Medical Biology, Russian National Research Medical University, Moscow, Russia
09/2022-present Principal Investigator/Professor, Oujiang Laboratory, Wnezhou, China
12/2015-08/2022 Associate Professor, Edward S. Harkness Eye Institute and Dept. of Pathology & Cell Biology, Columbia University, New York, NY, USA
08/2014-12/2015 Assistant Professor, Edward S. Harkness Eye Institute and Dept. of Pathology & Cell Biology, Columbia University, New York, NY, USA
07/2006-08/2014 Assistant Professor, Dept of Anatomy & Cell Ophthalmology, Wayne State University, Detroit, MI, USA
08/2003-06/2006 Assistant Professor, Storm Eye Institute and Dept of Cell Biology, Medical University of South Carolina, Charleston, SC, USA
08/2000-08/2003 Research Scientist, Dept of Neurobiology, Harvard Medical School, Boston, MA, USA
09/1998-07/2000 Medical University of South Carolina, Charleston, SC, USA
09/1996-08/1998 Inserm Poste Vert Scientist, Institute National De La Sante Et De La Recherche Medicale(INSERM), Montpellier, France
04/1995-08/1996 Senior Research Scientist, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
12/1992-03/1995 Research Scientist, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia
As a seasoned professional with a comprehensive background in biomedical research, Prof. Tkatchenko has brought a proven track record of innovative research across various disciplines. His expertise has earned recognition as a pioneer in myopia research, where his dedication to advancing our understanding and treatment of the disease is well- established. Leveraging the latest technologies and methodologies, His recent work in the pharmacogenomics of myopia has been instrumental in forging new paths for the development of effective medications aimed at combating myopia.
2022 Zhejiang Province Overseas Talent Award, Zhejiang, China
2021 Full member, Sigma Xi The Scientific Research Honor Society
2002&2001 Dana-Mahoney Research Award, Harvard Neuroscience Institute, Harvard University, Boston, MA, USA
1996 INSERM Poste Vert Award, Institut National de la Sante et de la Recherche Medicale (INSERM), France
1990 Distinguished Achievement Award, Outstanding Achievements in Scientific Research, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia
1. Zeitz C, Roger JE, Audo I, Michiels C, Sánchez-Farías N, Varin J, Frederiksen H, Wilmet B, Callebert J, Gimenez ML, Bouzidi N, Blond F, Guilllonneau X, Fouquet S, Léveillard T, Smirnov V, Vincent A, Héon E, Sahel JA, Kloeckener-Gruissem B, Sennlaub F, Morgans CW, Duvoisin RM, Tkatchenko AV*, Picaud S*. Shedding light on myopia by studying complete congenital stationary night blindness. Prog Retin Eye Res. 2023;101155. DOI: 10.1016/j.preteyeres.2022.101155.
2. Tkatchenko TV, Tkatchenko AV*. Genetic network regulating visual acuity makes limited contribution to visually guided eye emmetropization. Genomics. 2021; 113(4): 2780-2792.
3. Tkatchenko TV, Tkatchenko AV*§. Pharmacogenomic approach to antimyopia drug development: pathways lead the way. Trends Pharmacol Sci. 2019; 40(11): 834-853.
4. Tkatchenko AV, Walsh PA, Tkatchenko TV, Gustincich S, Raviola E. Form deprivation modulates retinal neurogenesis in primate experimental myopia. Proc. Natl. Acad. Sci. USA 2006; 103: 4681 – 4686.
5. Tkatchenko AV, Visconti RP, Shang L, Papenbrock T, Pruett ND, Ito T, Ogawa M, Awgulewitsch A. Overexpression of Hoxc13 in differentiating keratinocytes results in downregulation of a novel hair keratin gene cluster and alopecia. Development 2001; 128: 1547 – 1558.
